Antion teal logo (RA).png
Antion Biosciences Presents Preclinical Data at International Society of Cell & Gene Therapy (ISCT) Annual Meeting
May 25, 2021 02:00 ET | Antion Biosciences
PRESS RELEASE Antion Biosciences Presents Preclinical Data at International Society of Cell & Gene Therapy (ISCT) Annual Meeting Data demonstrates successful silencing of five target genes using...
Antion teal logo (RA).png
Antion Biosciences Presents New Data on miCARTM T-cells and Multiplex Gene Engineering Technology at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
May 12, 2021 02:00 ET | Antion Biosciences
PRESS RELEASE Antion Biosciences Presents New Data on miCARTM T-cells and Multiplex Gene Engineering Technology at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Novel miCAR™...
Antion teal logo (RA).png
Antion Biosciences to Present at Upcoming Scientific Conferences
April 13, 2021 07:00 ET | Antion Biosciences
PRESS RELEASE Antion Biosciences to Present at Upcoming Scientific Conferences -       Abstract acceptance at the American Society of Gene & Cell Therapy (ASGCT) Virtual Annual Meeting and the...
Antion teal logo (RA).png
Antion Biosciences to Present at Upcoming Scientific Conferences
April 13, 2021 02:00 ET | Antion Biosciences
PRESS RELEASE Antion Biosciences to Present at Upcoming Scientific Conferences -       Abstract acceptance at the American Society of Gene & Cell Therapy (ASGCT) Virtual Annual Meeting and the...
Antion teal logo (RA).png
Antion Biosciences Launches Novel Cell and Gene-engineering Platform, miCAR
March 18, 2021 07:00 ET | Antion Biosciences
PRESS RELEASE Antion Biosciences Launches Novel Cell and Gene-engineering Platform, miCARTM Company’s allogeneic miCAR™ T-cells have the potential to cure diseases with significant unmet needNovel...
Antion teal logo (RA).png
Antion Biosciences Launches Novel Cell and Gene-engineering Platform, miCAR
March 18, 2021 03:00 ET | Antion Biosciences
PRESS RELEASE Antion Biosciences Launches Novel Cell and Gene-engineering Platform, miCARTM Company’s allogeneic miCAR™ T-cells have the potential to cure diseases with significant unmet needNovel...